相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy
Xiao Mi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Clinical therapies and nano drug delivery systems for urinary bladder cancer
Pooja Jain et al.
PHARMACOLOGY & THERAPEUTICS (2021)
A Targeted Nano Drug Delivery System of AS1411 Functionalized Graphene Oxide Based Composites
Baoqing Liu et al.
CHEMISTRYOPEN (2021)
Stimuli-responsive charge-reversal nano drug delivery system: The promising targeted carriers for tumor therapy
Zengjun Fang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer
Jiyang Xue et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells
Hongjuan Yao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury
Hui Yu et al.
THERANOSTICS (2020)
Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog In Vitro
Xiaobei Zhang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Mammosphere Culture of Mammary Cells from Cynomolgus Macaques (Macaca fascicularis)
Silmi Mariya et al.
COMPARATIVE MEDICINE (2019)
Drug Delivery Based on Nanotechnology for Target Bone Disease
Xiaosong Yang et al.
CURRENT DRUG DELIVERY (2019)
Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic
Hong-Hui Wu et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy
Pingsheng Huang et al.
ACTA BIOMATERIALIA (2019)
Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers
Ahad Mokhtarzadeh et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Recent Progress of Nano-drug Delivery System for Liver Cancer Treatment
Feilong Zhou et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)
Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment
Usman Ali Ashfaq et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2017)
Therapeutic Nanoparticles Based on Curcumin and Bamboo Charcoal Nanoparticles for Chemo-Photothermal Synergistic Treatment of Cancer and Radioprotection of Normal Cells
Jiani Xie et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Delivery of macromolecules into the endothelium of whole ex vivo human cornea by femtosecond laser-activated carbon nanoparticles
Clotilde Jumelle et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells
Shuang Jiang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Folic Acid Functionalized γ-Cyclodextrin C60, A Novel Vehicle for Tumor-Targeted Drug Delivery
Yan Liu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis
Rachel Eyre et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2016)
The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells
Hong-juan Yao et al.
BIOMATERIALS (2014)
Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells
Qiang Yang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Association of metformin use with cancer incidence and mortality: A meta-analysis
Pengpeng Zhang et al.
CANCER EPIDEMIOLOGY (2013)
Autophagy contributes to the survival of CD 133+liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment
Yu-jiao Song et al.
CANCER LETTERS (2013)
Biology and clinical implications of CD133+ liver cancer stem cells
Stephanie Ma
EXPERIMENTAL CELL RESEARCH (2013)
CD133/Prominin-1-Mediated Autophagy and Glucose Uptake Beneficial for Hepatoma Cell Survival
Haiyang Chen et al.
PLOS ONE (2013)
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Monica Franciosi et al.
PLOS ONE (2013)
Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft
Jun Liu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Ovarian cancer stem cell markers: Prognostic and therapeutic implications
Daniela Burgos-Ojeda et al.
CANCER LETTERS (2012)
Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
Bin Bao et al.
CANCER PREVENTION RESEARCH (2012)
Understanding the benefit of metformin use in cancer treatment
Ryan J. O. Dowling et al.
BMC MEDICINE (2011)
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
Alejandro Vazquez-Martin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
Ines A. Silva et al.
CANCER RESEARCH (2011)
Biology of hepatic cancer stem cells
Carol Man Tong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Prominin-1 (CD133) Is Not Restricted to Stem Cells Located in the Basal Compartment of Murine and Human Prostate
Ewa Missol-Kolka et al.
PROSTATE (2011)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
Alejandro Vazquez-Martin et al.
CELL CYCLE (2010)
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16
Gijs W. D. Landman et al.
DIABETES CARE (2010)
Epigenetic regulation of cancer stem cells in liver cancer: Current concepts and clinical implications
J. U. Marquardt et al.
JOURNAL OF HEPATOLOGY (2010)
Using Activated Carbon Nanoparticles to Decrease the Genotoxicity and Teratogenicity of Anticancer Therapeutic Agents
Yang Zhong et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2010)
Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells
Ann H. Klopp et al.
PLOS ONE (2010)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
Yaojiong Wu et al.
STEM CELLS AND DEVELOPMENT (2009)
Cancer stem cells: A step toward the cure
Bruce M. Boman et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
S. Ma et al.
ONCOGENE (2008)
Identification and characterization of tumorigenic liver cancer stem/progenitor cells
Stephanie Ma et al.
GASTROENTEROLOGY (2007)
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells
Atsushi Suetsugi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Hepatocellular carcinoma: Overcoming challenges in disease management
RG Gish
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells
G Dontu et al.
BREAST CANCER RESEARCH (2004)
Molecular viral oncology of hepatocellular carcinoma
TM Block et al.
ONCOGENE (2003)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
Estimating the world cancer burden: GLOBOCAN 2000
DM Parkin et al.
INTERNATIONAL JOURNAL OF CANCER (2001)